Veterinary Stem Cell and Bioengineering Innovation Center (VSCBIC), Veterinary Pharmacology and Stem Cell Research Laboratory, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
Department of Biochemistry, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
J Vet Sci. 2021 Nov;22(6):e74. doi: 10.4142/jvs.2021.22.e74. Epub 2021 Aug 26.
Tissue engineering has been extensively investigated and proffered to be a potential platform for novel tissue regeneration. The utilization of mesenchymal stem cells (MSCs) from various sources has been widely explored and compared. In this regard, MSCs derived from bone marrow have been proposed and described as a promising cell resource due to their high yield of isolated cells with colony-forming potential, self-renewal capacity, MSC surface marker expression, and multi-lineage differentiation capacities . However, there is evidence for bone marrow MSCs (BM-MSCs) both and from different species presenting identical and distinct potential stemness characteristics. In this review, the fundamental knowledge of the growth kinetics and stemness properties of BM-MSCs in different animal species and humans are compared and summarized. Finally, to provide a full perspective, this review will procure results of current information studies focusing on the use of BM-MSCs in clinical practice.
组织工程学已经得到了广泛的研究,并被提出作为一种新的组织再生的潜在平台。利用来自不同来源的间充质干细胞(MSCs)已经得到了广泛的探索和比较。在这方面,骨髓来源的 MSCs 由于其具有高产量的分离细胞、集落形成潜力、自我更新能力、MSC 表面标记物表达和多向分化能力,被提出并描述为一种有前途的细胞资源。然而,有证据表明不同物种的骨髓间充质干细胞(BM-MSCs)既有相同的又有不同的潜在干细胞特性。在这篇综述中,比较和总结了不同动物物种和人类的 BM-MSCs 的生长动力学和干细胞特性的基本知识。最后,为了提供全面的视角,本文综述将收集目前关注 BM-MSCs 在临床实践中应用的信息研究结果。